A Randomized Control Open Label Clinical Trial on the Efficacy of Shatapushpa Churna and Madhutailika Basti in Nashtartava w. s. r. to Polycystic Ovarian Syndrome

Introduction (Background) - The health of society depends largely on the health ofwomen. A woman should have normal regular menstrual cycle in order to maintain normal reproductive health. Now a day, Polycystic Ovarian Syndrome is becoming a major health problem worldwide. It is a major non-communicable health problem affecting the women of different age groups. Methods - 33 clinically diagnosed patients of Nashtartava were selected from OPD and IPD of Prasuti Tantra and Stri Roga department of NIA, Jaipur as per criteria of inclusion. These patients were randomly divided into two groups and the study was completed on 30 patients;15 patients in each group. Result - It was found on comparing both the groups on the basis of symptomatic improvement, that, average percentage of relief was higher in ‘Group A’ i.e., 67.41%, while that in case of ‘Group B’ was found 55.92%. Thus, the effect of therapy was found more in ‘Group A’ in comparison to ‘Group B’. Conclusion - Shatapushpa Churna was found more effective than Madhutailika Basti in improving the symptoms of Nashtartava (w. s. r. to PCOS).